GI Effects is unlike any other stool analysis profile, going beyond the standard parameters for identifying gastrointestinal disorders.
The GI Effects Profile uses DNA analysis to identify microbiota including anaerobes, a previously immeasurable area of the gut environment. DNA assessment is specific and accurate, avoids the pitfalls of sample transport, reports results as specific numbers, and is more sensitive than classic laboratory methods.
Download the White Paper on documented limitations of culture based stool assessment.
The Mycology Profile is also an easy and cost-effective follow-up testing option to monitor targeted therapy in patients for yeast/fungi overgrowth.
Yeast in small amounts is considered normal. However, yeast overgrowth in the gut has been linked to many chronic conditions, in part because of antigenic responses in some patients to even low rates of yeast growth. Potential symptoms can include diarrhea, headache, bloating, atopic dermatitis, and fatigue. The GI Effects Mycology Profile identifies yeast and fungi, in real quantitative amounts, as well as fungal sensitivities of pharmaceuticals and botanicals.
"PCR is the best developed and most widely used nucleic acid amplification strategy...These techniques have sensitivity unparalleled in laboratory medicine, have created new opportunities for the clinical laboratory to have an effect on patient care and have become the new "gold standards" for laboratory diagnosis of several infectious diseases."
-Manual of Clinical Microbiology, 8th Edition, Vol. 1, page 235, 2003